ThomasYvanRegenbogenMD

PubMed

• Choosing and managing a career as a community practitioner.
  Thomas Regenbogen> ;Clinical Advances in Hematology & Oncology. 2019 Jan 1
• 9 citations
  Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer.
  Thomas Regenbogen, Ling Chen, Kathryn Trinkaus, Andrea Wang-Gillam, Benjamin R. Tan, Manik Amin, Katrina S. Pedersen, Haeseong Park, Rama Suresh, Kian-Huat Lim, Emily ...> ;Journal of Gastrointestinal Oncology. 2017 Dec 1
• 17 citations
  State of the Art: Concise ReviewReview of Ongoing Clinical Trials in Non–Small-Cell Lung Cancer: A Status Report for 2012 from the ClinicalTrials.gov Web Site
  Janakiraman Subramanian, Thomas Regenbogen, Gayathri Nagaraj, Siddhartha Devarakonda, Gongfu Zhou, Ramaswamy Govindan> ;Journal of Thoracic Oncology. 2013 Jul 1
• 7 citations
  Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website.
  Janakiraman Subramanian, Anusha R Madadi, Monica Dandona, Kristina Williams, Daniel Morgensztern, Ramaswamy Govindan> ;Journal of Thoracic Oncology. 2010 Aug 1
• Join now to see all

Books/Book Chapters

• The Washington Manual of Outpatient Internal Medicine 
  Chapter: Hematology 
  Regenbogen T, Blinder M.Editors: Sateia H, DeFer T.Lippincott Williams and Wilkins, PhiladelphiaEdition 2,2015
• The Washington Manual of Medical Therapeutics 
  Chapter: Hematology 
  Blinder M, Regenbogen T, Zhou A.Editors: Ramgopal R, et al..Lippincott Williams and Wilkins, PhiladelphiaEdition 35,2015